Stage 4 Metastatic Lung Cancer Treatment - Elaina's Envita Review

Left with limited options to treat her rare type of stage 4 lung cancer, Elaina chose to not give up and continue her search for the right treatment. “She said there was nothing I could do to save my own life,” said Elaina Lawrence, referring to her prognosis in standard of care oncology. To overcome this grim prognosis, Elaina traveled from Texas to Envita Medical Centers, a Center of Excellence for Precision Integrative Oncology, located in Scottsdale, Arizona.

Lack of Options in the One-Size-Fits-All Approach

Elaina was diagnosed with Pulmonary Enteric Adenocarcinoma, which is a rare and invasive subtype of Non-Small Cell Lung Cancer (NSCLC), after manifesting symptoms of pleural effusion. By the time the cancer was diagnosed, it had already spread to her lymph nodes and bone. Due to the rarity of her disease type, there were limited options for her in the standard of care one-size-fits all approach.

However, at Envita, our team of specially trained physicians' custom-develop treatment protocols, by identifying the unique set of causes responsible for triggering the disease in each individual patient. This detailed approach, based on in-depth genomic analysis and other specialty tests, is designed to overcome the limitations of standard one-size-fits-all protocols, which is especially helpful for patients with rare types of cancers, like Elaina's.

Proprietary Precision Targeted Treatments and Immunotherapies

Elaina responded extremely well to our precision targeted treatments, including GTFC™ (Genetically Targeted Fractionated Chemotherapy), CIPI™ (Chemo Immuno Precision Injections), and cryoablations. GTFC™ is our proprietary low-dose chemotherapy designed to enhance the mechanisms of action against the cancerous cells without impacting the surrounding healthy cells, while CIPI™ is our interventional radiology procedure to precisely target inoperable tumors. This minimally invasive procedure is designed to deploy personalized medications including targeted chemotherapy and immunotherapy agents at the tumor site to deactivate the tumor and proactively identify and treat cancerous cells elsewhere in the body. “It doesn't kill everything in your body... it targets just cancer cells, to me that's genius!” added Elaina, impressed with our approach of targeting the disease core, while aiming for reducing the chances of recurrence and further spread.

Her Envita Connection

She feels fortunate to have been a part of a cancer support group, because that is where she heard about the optimistic results of one of our patients, which motivated her to pursue care at Envita. “With Envita's care, my quality of life has obviously improved because I'm healthy, going home, but even during treatments, my quality of life was there,” said Elaina, who was also treated for Lyme disease, which was discovered during the course of her lung cancer treatment. “I can't stress enough that this is not a doom and gloom environment, Envita is life,” said Elaina. She is ecstatic about her response to care and wishes for every cancer patient to have a chance at emulating her road to recovery. “To go from there's nothing you can do to save your life to ringing the bell and walking out the door knowing that you've beaten down the cancer, there's no greater feeling than that!” added Elaina.

Call Us Today

Envita's specially trained team consists of oncologists, interventional radiologists, researchers, and pharmacists, who undergo over 1,500 hours of intensive training in the unique approach of personalized precision oncology. They collaborate to develop tailored treatment strategies to potentially improve the patient's quality of life, increase longevity, and reduce toxicities. For any inquiries regarding cancer, feel free to reach out to us at 866-830-4576.